Contact: Colleen Hayes firstname.lastname@example.org 608-263-6387 University of Wisconsin-Madison Mouse studies reveal promising vitamin D-based treatment for MS MADISON — A diagnosis of multiple sclerosis (MS) is a hard lot. Patients typically get the diagnosis around age 30 after experiencing a… Read More ›
Contact: Rachel Seroka email@example.com 612-928-6129 American Academy of Neurology MINNEAPOLIS – New evidence suggests that taking vitamin B supplements may help reduce the risk of stroke. The research appears in the September 18, 2013, online issue of Neurology®, the medical… Read More ›
Contact: Rachel Seroka firstname.lastname@example.org 612-928-6129 American Academy of Neurology MINNEAPOLIS – A new study shows that people who have had a head injury and have lived or worked near areas where the pesticide paraquat was used may be three times… Read More ›
Children with MS were 1.74 times more likely to have received a certain type of hepatitis B vaccine, called Engerix B®. Those children with MS developed symptoms three or more years after the vaccine.
Public release date: 25-Sep-2008 Re-Posted for Filing Contact: Rachel Seroka email@example.com 651-695-2738 American Academy of Neurology Majority of children vaccinated against hepatitis B not at increased risk of MS ST. PAUL, Minn. – The majority of children vaccinated against hepatitis… Read More ›
Re-post 34th HRR 2008 Contact: Tom Rickey firstname.lastname@example.org 585-275-7954 University of Rochester Medical Center Cholesterol-lowering drugs known as statins have a profound effect on an elite group of cells important to brain health as we age, scientists at the University… Read More ›
Research: Honorary and ghost authorship in high impact biomedical journals – a cross sectional survey Just over one in five (21%) of articles published in six leading medical journals in 2008 have evidence of honorary and ghost authorship,… Read More ›